TYK Medicines, Inc (HKG:2410)

TYK Medicines Statistics

Total Valuation

TYK Medicines has a market cap or net worth of HKD 4.25 billion. The enterprise value is 4.01 billion.

Market Cap	4.25B
Enterprise Value	4.01B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

TYK Medicines has 384.67 million shares outstanding. The number of shares has increased by 10.94% in one year.

Current Share Class	384.67M
Shares Outstanding	384.67M
Shares Change (YoY)	+10.94%
Shares Change (QoQ)	+2.00%
Owned by Insiders (%)	2.08%
Owned by Institutions (%)	24.27%
Float	235.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	13.32
P/TBV Ratio	16.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.53.

Current Ratio	1.43
Quick Ratio	1.29
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21.62

Financial Efficiency

Return on equity (ROE) is -80.61% and return on invested capital (ROIC) is -37.03%.

Return on Equity (ROE)	-80.61%
Return on Assets (ROA)	-23.78%
Return on Invested Capital (ROIC)	-37.03%
Return on Capital Employed (ROCE)	-68.34%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-1.93M
Employee Count	173
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-59.78%
50-Day Moving Average	11.48
200-Day Moving Average	14.67
Relative Strength Index (RSI)	50.47
Average Volume (20 Days)	2,407,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-358.93M
Pretax Income	-340.49M
Net Income	-333.58M
EBITDA	-342.31M
EBIT	-358.93M
Earnings Per Share (EPS)	-0.89

Balance Sheet

The company has 408.72 million in cash and 170.05 million in debt, with a net cash position of 238.67 million or 0.62 per share.

Cash & Cash Equivalents	408.72M
Total Debt	170.05M
Net Cash	238.67M
Net Cash Per Share	0.62
Equity (Book Value)	318.94M
Book Value Per Share	0.84
Working Capital	148.30M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	17.15M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYK Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.94%
Shareholder Yield	-10.94%
Earnings Yield	-7.85%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a